GlassScriptPhysician profile
Michael W Davis
NPI 1053343673
$2,309.60
in general payments reported to CMS, 2019-2025
22 companies · $553 in 2025
The $553 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $53.65 · 2021: $302 · 2022: $381 · 2023: $405 · 2024: $431 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,110.95 |
| Education | $276.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $609.72 | 2019-2025 | Veozah |
| Abbvie INC. | $529.36 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Daiichi Sankyo INC. | $258.69 | 2021-2025 | Injectafer |
| Stryker Corporation | $126.45 | 2025 | Optablate |
| Merck Sharp & Dohme LLC | $112.49 | 2019-2021 | |
| Exact Sciences Corporation | $91.50 | 2023-2025 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $90.13 | 2025 | Voquezna |
| Organon LLC | $71.38 | 2021-2023 | Nexplanon |
| Coopersurgical, INC. | $46.13 | 2019-2025 | Endosee |
| Mayne Pharma Commercial LLC | $45.35 | 2025 | |
| Pfizer INC. | $43.41 | 2019-2022 | |
| Biogen, INC. | $43.02 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $39.94 | 2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $39.22 | 2019-2024 | |
| Therapeuticsmd, INC. | $34.43 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $25.83 | 2023 | Myfembree |
| Medtronic, INC. | $24.32 | 2025 | Kyphon Express II Kyphopak Tray |
| Medtronic Vascular, INC. | $20.36 | 2019 | |
| Becton, Dickinson and Company | $16.02 | 2024 | Bd Onclarity |
| Vertical Pharmaceuticals, LLC | $14.99 | 2020 | |
| Hologic Sales and Service, LLC | $13.67 | 2021 | |
| Alydia Health | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.